Man’s asthma inhaler cost went from $66 to $539, then he died, Wisconsin lawsuit says
The family of a Wisconsin man is suing after they say he died from an asthma attack when his medication price rose from $66 ...
PharmiWeb20 小时
Depemokimab accepted for review by the European Medicines Agency for use in asthma with ...
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...
PharmiWeb20 小时
Depemokimab applications accepted for review in China and Japan for asthma with type 2 ...
GSK plc (LSE/NYSE: GSK) today announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, ...